BIOLOGICAL EFFECTS OF A HUMAN IGG4 MONOCLONAL-ANTIBODY IN-VIVO

BIOLOGICAL EFFECTS OF A HUMAN IGG4 MONOCLONAL-ANTIBODY IN-VIVO

Xehetasun bibliografikoak
Egile Nagusiak:	Isaacs, J, Greenwood, J, Wing, M, Hale, G, Waldmann, H
Formatua:	Journal article
Argitaratua:	1995

Antzeko izenburuak

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
nork: Isaacs, J, et al.
Argitaratua: (1996)

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
nork: Isaacs, J, et al.
Argitaratua: (1992)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
nork: Isaacs, J, et al.
Argitaratua: (1992)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
nork: Lockwood, C, et al.
Argitaratua: (1993)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
nork: Lockwood, C, et al.
Argitaratua: (1995)

Therapy with monoclonal antibodies. II. The contribution of Fc gamma receptor binding and the influence of C(H)1 and C(H)3 domains on in vivo effector function.
nork: Isaacs, J, et al.
Argitaratua: (1998)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
nork: Lockwood, C, et al.
Argitaratua: (1996)

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
nork: Isaacs, J, et al.
Argitaratua: (1997)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
nork: Lockwood, C, et al.
Argitaratua: (1993)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
nork: Isaacs, J, et al.
Argitaratua: (1992)

Interaction of rat monoclonal antibodies with human killer cells.
nork: Clark, M, et al.
Argitaratua: (1985)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
nork: Kyle, V, et al.
Argitaratua: (1991)

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply
nork: Isaacs, J, et al.
Argitaratua: (2002)

MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
nork: Isaacs, J, et al.
Argitaratua: (1993)

Structural motifs involved in human IgG antibody effector functions.
nork: Greenwood, J, et al.
Argitaratua: (1993)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
nork: Isaacs, J, et al.
Argitaratua: (1998)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
nork: Isaacs, J, et al.
Argitaratua: (1996)

Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
nork: Bindon, C, et al.
Argitaratua: (1988)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
nork: Isaacs, J, et al.
Argitaratua: (2004)

Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodies.
nork: Isaacs, J, et al.
Argitaratua: (1994)

Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype.
nork: Wing, MG, et al.
Argitaratua: (1995)

Advantages of rat monoclonal antibodies.
nork: Clark, M, et al.
Argitaratua: (1983)

INTERACTION OF RAT MONOCLONAL-ANTIBODIES WITH HUMAN KILLER CELLS (K-CELLS)
nork: Hale, G, et al.
Argitaratua: (1984)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
nork: Isaacs, J, et al.
Argitaratua: (2005)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
nork: Isaacs, J, et al.
Argitaratua: (2005)

Specificity of monoclonal antibody Campath-1.
nork: Hale, G, et al.
Argitaratua: (1988)

Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study.
nork: Morgan, A, et al.
Argitaratua: (1997)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
nork: Hale, G, et al.
Argitaratua: (1994)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
nork: Dyer, M, et al.
Argitaratua: (1988)

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.
nork: Hale, G, et al.
Argitaratua: (1985)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
nork: Waldmann, H, et al.
Argitaratua: (2001)

Human monoclonal antibodies: the residual challenge of antibody immunogenicity.
nork: Waldmann, H
Argitaratua: (2014)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
nork: Newman, D, et al.
Argitaratua: (1995)

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
nork: Bindon, C, et al.
Argitaratua: (1985)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
nork: Isaacs, J, et al.
Argitaratua: (1995)

MONOCLONAL-ANTIBODIES TO HEMATOPOIETIC-CELLS
nork: Waldmann, H, et al.
Argitaratua: (1982)

Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
nork: Lawson, C, et al.
Argitaratua: (2005)

The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies.
nork: Clark, M, et al.
Argitaratua: (1989)

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.
nork: Cobbold, S, et al.
Argitaratua: (1984)

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
nork: Bindon, C, et al.
Argitaratua: (1988)